Episode Player
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
The Lancet Neurology in conversation with
The Lancet Neurology in conversation with
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
Jul 16, 2025
The Lancet Group
In this episode, host Laura Hart chats with Professor Amit Bar-Or (University of Pennsylvania) about the potential of the BTK inhibitor fenebrutinib in treating relapsing multiple sclerosis, highlighting future challenges in MS research.
Read the full article:
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
